Patient Data and SUVs Measured in Each Lesion
| Time between 18F-FDG and AMT PET | SUV | |||||||
|---|---|---|---|---|---|---|---|---|
| Patient no. | Sex | Age (y) | Diagnosis | Previous therapy (before AMT) | Lesion no. | 18F-FDG | AMT | |
| 1 | F | 54 | Thymic cyst | None | 18F-FDG PET not done | 1 | — | 0.5 |
| 2 | M | 39 | Hamartoma | None | 54 d (18F-FDG later) | 1 | 0.9 | 0.7 |
| 3 | M | 66 | Metastasis (rectal cancer) | None | 11 d | 1 | 2.8 | 1.3 |
| 4 | M | 58 | NSCLC (scc) | Chemotherapy (2 wk)* | 1 mo | 1 | 15.7 | 2.5 |
| 5 | F | 58 | NSCLC (pd) | Radiotherapy + chemotherapy (>6 mo)† | 1 mo | 1 | 8.0 | 5.5 |
| 2 | 6.8 | 4.4 | ||||||
| 6 | F | 56 | NSCLC (lcc) | Radiotherapy + chemotherapy (>6 mo)† | 7 d | 1 | 5.5 | 2.4 |
| 2 | 2.8 | 2.7 | ||||||
| 3 | 3 | 2.6 | ||||||
| 4 | 2.7 | 1.6 | ||||||
| 5 | 2.7 | 2.7 | ||||||
| 7 | M | 79 | NSCLC (acc) | None | 6 d | 1 | 2.8 | 1.2 |
| 8 | M | 49 | NSCLC (scc) | None | 11 d | 1 | 7.3 | 2.1 |
| 2 | 3.3 | 1.7 | ||||||
| 9 | F | 47 | NSCLC (acc) | None | 18F-FDG PET not done | 1 | — | 3.2 |
| 2 | — | 3.0 | ||||||
| 10 | M | 46 | NSCLC (pd) | None | 28 d | 1 | 4.7 | 1.9 |
| 2 | 1.6 | 0.8 | ||||||
↵* Therapy started after 18F-FDG PET but 2 wk before AMT PET scan.
↵† Therapy was finished more than 6 mo before AMT PET scan.
scc = squamous cell carcinoma; pd = poorly differentiated carcinoma; lcc = large cell carcinoma; acc = adenocarcinoma.
Tumors are consecutively numbered in patients with multiple lesions.